Follow
srinivas bandaru
srinivas bandaru
Institute of Genetics, Hyderabad -500 016, India
Verified email at bioclues.org
Title
Cited by
Cited by
Year
Virtual screening approaches in identification of bioactive compounds Akin to delphinidin as potential HER2 inhibitors for the treatment of breast cancer
K Patidar, A Deshmukh, S Bandaru, C Lakkaraju, A Girdhar, G Vr, ...
Asian Pacific Journal of Cancer Prevention 17 (4), 2291-2295, 2016
402016
Molecular dynamic simulations reveal suboptimal binding of salbutamol in T164I variant of β2 adrenergic receptor
S Bandaru, M Alvala, A Nayarisseri, S Sharda, H Goud, HP Mundluru, ...
PloS one 12 (10), e0186666, 2017
392017
Immunotherapeutic approach for better management of cancer-role of IL-18
MB Kuppala, SB Syed, S Bandaru, S Varre, J Akka, HP Mundulru
Asian Pacific Journal of Cancer Prevention 13 (11), 5353-5361, 2012
382012
A virtual screening approach for the identification of high affinity small molecules targeting BCR-ABL1 inhibitors for the treatment of chronic myeloid leukemia
S Sharda, P Sarmandal, S Cherukommu, K Dindhoria, M Yadav, ...
Current topics in medicinal chemistry 17 (26), 2989-2996, 2017
372017
Structure-based design of gRNA for Cas13
S Bandaru, MH Tsuji, Y Shimizu, K Usami, S Lee, NK Takei, K Yoshitome, ...
Scientific reports 10 (1), 11610, 2020
362020
Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives
MM Sahila, PP Babitha, S Bandaru, A Nayarisseri, VA Doss
Bioinformation 11 (6), 280, 2015
362015
Molecular Docking studies of FKBP12-mTOR inhibitors using binding predictions
AB Nasr, D Ponnala, SR Sagurthi, RK Kattamuri, VK Marri, S Gudala, ...
Bioinformation 11 (6), 307, 2015
362015
High affinity pharmacological profiling of dual inhibitors targeting RET and VEGFR2 in inhibition of kinase and angiogeneis events in medullary thyroid carcinoma
NR Dunna, V Kandula, A Girdhar, A Pudutha, T Hussain, S Bandaru, ...
Asian Pacific Journal of Cancer Prevention 16 (16), 7089-7095, 2015
352015
Molecular Docking and pharmacological investigations of rivastigmine-fluoxetine and coumarin–tacrine hybrids against acetyl choline esterase
PP Babitha, MM Sahila, S Bandaru, A Nayarisseri, S Sureshkumar
Bioinformation 11 (8), 378, 2015
342015
An in silico approach for identification of novel inhibitors as a potential therapeutics targeting HIV-1 viral infectivity factor
C Sinha, A Nischal, S Bandaru, P Kasera, A Rajput, A Nayarisseri, ...
Current Topics in Medicinal Chemistry 15 (1), 65-72, 2015
342015
Molecular docking approaches in identification of High affinity inhibitors of Human SMO receptor
UR Akare, S Bandaru, U Shaheen, PK Singh, G Tiwari, P Singare, ...
Bioinformation 10 (12), 737, 2014
332014
Design and synthesis of chiral 2H-chromene-N-imidazolo-amino acid conjugates as aldose reductase inhibitors
G Gopinath, V Sankeshi, MD Alaparthi, S Bandaru, VK Pasala, ...
European Journal of Medicinal Chemistry 124, 750-762, 2016
322016
Association of Beta 2 adrenergic receptor (Thr164Ile) polymorphism with Salbutamol refractoriness in severe asthmatics from Indian population
S Bandaru, P Tarigopula, J Akka, VK Marri, RK Kattamuri, A Nayarisseri, ...
Gene 592 (1), 15-22, 2016
322016
Computer aided identification of sodium channel blockers in the clinical treatment of epilepsy using molecular docking tools
U Shaheen, J Akka, JS Hinore, A Girdhar, S Bandaru, TG Sumithnath, ...
Bioinformation 11 (3), 131, 2015
322015
Identification of high affinity non-peptidic small molecule inhibitors of MDM2-p53 interactions through structure-based virtual screening strategies
S Bandaru, D Ponnala, C Lakkaraju, CK Bhukya, U Shaheen, ...
Asian Pacific Journal of Cancer Prevention 16 (9), 3759-3765, 2015
312015
Structure based virtual screening of ligands to identify cysteinyl leukotriene receptor 1 antagonist
S Bandaru, VK Marri, P Kasera, P Kovuri, A Girdhar, DR Mittal, S Ikram, ...
Bioinformation 10 (10), 652, 2014
312014
Design, synthesis and computational evaluation of a novel intermediate salt of N-cyclohexyl-N-(cyclohexylcarbamoyl)-4-(trifluoromethyl) benzamide as potential potassium channel …
V Natchimuthu, S Bandaru, A Nayarisseri, S Ravi
Computational biology and chemistry 64, 64-73, 2016
302016
An in silico appraisal to identify high affinity anti-apoptotic synthetic tetrapeptide inhibitors targeting the mammalian caspase 3 enzyme
S Kelotra, M Jain, A Kelotra, I Jain, S Bandaru, A Nayarisseri, A Bidwai
Asian Pacific Journal of Cancer Prevention 15 (23), 10137-10142, 2015
302015
Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibition
C Sinha, A Nischal, KK Pant, S Bandaru, A Nayarisseri, S Khattri
Bioinformation 10 (10), 611, 2014
302014
Identification of small molecule as a high affinity β2 agonist promiscuously targeting wild and mutated (Thr164Ile) β 2 adrenergic receptor in the treatment of bronchial asthma
S Bandaru, M Alvala, J Akka, SR Sagurthi, A Nayarisseri, S Kumar Singh, ...
Current pharmaceutical design 22 (34), 5221-5233, 2016
292016
The system can't perform the operation now. Try again later.
Articles 1–20